Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > CMYA5(Gene name) > Human
  • Add your favorite
  • CMYA5 (Gene name),
  • Cardiomyopathy-associated protein 5 (Protein name ),  CMYA5_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    CMYA5(C5orf10;DTNBP2;SPRYD2;TRIM76);
    Protein name:
    Cardiomyopathy-associated protein 5;
    Alternative:
    Genethonin-3;Dystrobrevin-binding protein 2;SPRY domain-containing protein 2;Myospryn;Tripartite motif-containing protein 76;
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    Interacts with ACTN2, DTNBP1/dysbindin and PRKAR2A (By similarity). Interacts with DES.
    Function:
    N/A
    Subcellular Location:
    Cytoplasm Cytoplasm perinuclear region Found predominantly at the periphery of the nucleus but also throughout the cell. Localized at the Z-line costamere connection level of the sarcolemma and in lysosomes.
    Protein Attributes:
    Sequence length:
    4069
    Sequence:
    50:
    MASRDSNHAG | ESFLGSDGDE | EATRELETEE | ESEGEEDETA | AESEEEPDSR | 
    100:
    LSDQDEEGKI | KQEYIISDPS | FSMVTVQRED | SGITWETNSS | RSSTPWASEE | 
    150:
    SQTSGVCSRE | GSTVNSPPGN | VSFIVDEVKK | VRKRTHKSKH | GSPSLRRKGN | 
    200:
    RKRNSFESQD | VPTNKKGSPL | TSASQVLTTE | KEKSYTGIYD | KARKKKTTSN | 
    250:
    TPPITGAIYK | EHKPLVLRPV | YIGTVQYKIK | MFNSVKEELI | PLQFYGTLPK | 
    300:
    GYVIKEIHYR | KGKDASISLE | PDLDNSGSNT | VSKTRKLVAQ | SIEDKVKEVF | 
    350:
    PPWRGALSKG | SESLTLMFSH | EDQKKIYADS | PLNATSALEH | TVPSYSSSGR | 
    400:
    AEQGIQLRHS | QSVPQQPEDE | AKPHEVEPPS | VTPDTPATMF | LRTTKEECEL | 
    450:
    ASPGTAASEN | DSSVSPSFAN | EVKKEDVYSA | HHSISLEAAS | PGLAASTQDG | 
    500:
    LDPDQEQPDL | TSIERAEPVS | AKLTPTHPSV | KGEKEENMLE | PSISLSEPLM | 
    550:
    LEEPEKEEIE | TSLPIAITPE | PEDSNLVEEE | IVELDYPESP | LVSEKPFPPH | 
    600:
    MSPEVEHKEE | ELILPLLAAS | SPEHVALSEE | EREEIASVST | GSAFVSEYSV | 
    650:
    PQDLNHELQE | QEGEPVPPSN | VEAIAEHAVL | SEEENEEFEA | YSPAAAPTSE | 
    700:
    SSLSPSTTEK | TSENQSPLFS | TVTPEYMVLS | GDEASESGCY | TPDSTSASEY | 
    750:
    SVPSLATKES | LKKTIDRKSP | LILKGVSEYM | IPSEEKEDTG | SFTPAVAPAS | 
    800:
    EPSLSPSTTE | KTSECQSPLP | STATSEHVVP | SEGEDLGSER | FTPDSKLISK | 
    850:
    YAAPLNATQE | SQKKIINEAS | QFKPKGISEH | TVLSVDGKEV | IGPSSPDLVV | 
    900:
    ASEHSFPPHT | TEMTSECQAP | PLSATPSEYV | VLSDEEAVEL | ERYTPSSTSA | 
    950:
    SEFSVPPYAT | PEAQEEEIVH | RSLNLKGASS | PMNLSEEDQE | DIGPFSPDSA | 
    1000:
    FVSEFSFPPY | ATQEAEKREF | ECDSPICLTS | PSEHTILSDE | DTEEAELFSP | 
    1050:
    DSASQVSIPP | FRISETEKNE | LEPDSLLTAV | SASGYSCFSE | ADEEDIGSTA | 
    1100:
    ATPVSEQFSS | SQKQKAETFP | LMSPLEDLSL | PPSTDKSEKA | EIKPEIPTTS | 
    1150:
    TSVSEYLILA | QKQKTQAYLE | PESEDLIPSH | LTSEVEKGER | EASSSVAAIP | 
    1200:
    AALPAQSSIV | KEETKPASPH | SVLPDSVPAI | KKEQEPTAAL | TLKAADEQMA | 
    1250:
    LSKVRKEEIV | PDSQEATAHV | SQDQKMEPQP | PNVPESEMKY | SVLPDMVDEP | 
    1300:
    KKGVKPKLVL | NVTSELEQRK | LSKNEPEVIK | PYSPLKETSL | SGPEALSAVK | 
    1350:
    MEMKHDSKIT | TTPIVLHSAS | SGVEKQVEHG | PPALAFSALS | EEIKKEIEPS | 
    1400:
    SSTTTASVTK | LDSNLTRAVK | EEIPTDSSLI | TPVDRPVLTK | VGKGELGSGL | 
    1450:
    PPLVTSADEH | SVLAEEDKVA | IKGASPIETS | SKHLAWSEAE | KEIKFDSLPS | 
    1500:
    VSSIAEHSVL | SEVEAKEVKA | GLPVIKTSSS | QHSDKSEEAR | VEDKQDLLFS | 
    1550:
    TVCDSERLVS | SQKKSLMSTS | EVLEPEHELP | LSLWGEIKKK | ETELPSSQNV | 
    1600:
    SPASKHIIPK | GKDEETASSS | PELENLASGL | APTLLLLSDD | KNKPAVEVSS | 
    1650:
    TAQGDFPSEK | QDVALAELSL | EPEKKDKPHQ | PLELPNAGSE | FSSDLGRQSG | 
    1700:
    SIGTKQAKSP | ITETEDSVLE | KGPAELRSRE | GKEENRELCA | SSTMPAISEL | 
    1750:
    SSLLREESQN | EEIKPFSPKI | ISLESKEPPA | SVAEGGNPEE | FQPFTFSLKG | 
    1800:
    LSEEVSHPAD | FKKGGNQEIG | PLPPTGNLKA | QVMGDILDKL | SEETGHPNSS | 
    1850:
    QVLQSITEPS | KIAPSDLLVE | QKKTEKALHS | DQTVKLPDVS | TSSEDKQDLG | 
    1900:
    IKQFSLMREN | LPLEQSKSFM | TTKPADVKET | KMEEFFISPK | DENWMLGKPE | 
    1950:
    NVASQHEQRI | AGSVQLDSSS | SNELRPGQLK | AAVSSKDHTC | EVRKQVLPHS | 
    2000:
    AEESHLSSQE | AVSALDTSSG | NTETLSSKSY | SSEEVKLAEE | PKSLVLAGNV | 
    2050:
    ERNIAEGKEI | HSLMESESLL | LEKANTELSW | PSKEDSQEKI | KLPPERFFQK | 
    2100:
    PVSGLSVEQV | KSETISSSVK | TAHFPAEGVE | PALGNEKEAH | RSTPPFPEEK | 
    2150:
    PLEESKMVQS | KVIDDADEGK | KPSPEVKIPT | QRKPISSIHA | REPQSPESPE | 
    2200:
    VTQNPPTQPK | VAKPDLPEEK | GKKGISSFKS | WMSSLFFGSS | TPDNKVAEQE | 
    2250:
    DLETQPSPSV | EKAVTVIDPE | GTIPTNFNVA | EKPADHSLSE | VKLKTADEPR | 
    2300:
    GTLVKSGDGQ | NVKEKSMILS | NVEDLQQPKF | ISEVSREDYG | KKEISGDSEE | 
    2350:
    MNINSVVTSA | DGENLEIQSY | SLIGEKLVME | EAKTIVPPHV | TDSKRVQKPA | 
    2400:
    IAPPSKWNIS | IFKEEPRSDQ | KQKSLLSFDV | VDKVPQQPKS | ASSNFASKNI | 
    2450:
    TKESEKPESI | ILPVEESKGS | LIDFSEDRLK | KEMQNPTSLK | ISEEETKLRS | 
    2500:
    VSPTEKKDNL | ENRSYTLAEK | KVLAEKQNSV | APLELRDSNE | IGKTQITLGS | 
    2550:
    RSTELKESKA | DAMPQHFYQN | EDYNERPKII | VGSEKEKGEE | KENQVYVLSE | 
    2600:
    GKKQQEHQPY | SVNVAESMSR | ESDISLGHSL | GETQSFSLVK | ATSVTEKSEA | 
    2650:
    MLAEAHPEIR | EAKAVGTQPH | PLEESKVLVE | KTKTFLPVAL | SCRDEIENHS | 
    2700:
    LSQEGNLVLE | KSSRDMPDHS | EEKEQFRESE | LSKGGSVDIT | KETVKQGFQE | 
    2750:
    KAVGTQPRPL | EESKVLVEKT | KTFLPVVLSC | HDEIENHSLS | QEGNLVLEKS | 
    2800:
    SRDMPDHSEE | KEQFKESELW | KGGSVDITKE | SMKEGFPSKE | SERTLARPFD | 
    2850:
    ETKSSETPPY | LLSPVKPQTL | ASGASPEINA | VKKKEMPRSE | LTPERHTVHT | 
    2900:
    IQTSKDDTSD | VPKQSVLVSK | HHLEAAEDTR | VKEPLSSAKS | NYAQFISNTS | 
    2950:
    ASNADKMVSN | KEMPKEPEDT | YAKGEDFTVT | SKPAGLSEDQ | KTAFSIISEG | 
    3000:
    CEILNIHAPA | FISSIDQEES | EQMQDKLEYL | EEKASFKTIP | LPDDSETVAC | 
    3050:
    HKTLKSRLED | EKVTPLKENK | QKETHKTKEE | ISTDSETDLS | FIQPTIPSEE | 
    3100:
    DYFEKYTLID | YNISPDPEKQ | KAPQKLNVEE | KLSKEVTEET | ISFPVSSVES | 
    3150:
    ALEHEYDLVK | LDESFYGPEK | GHNILSHPET | QSQNSADRNV | SKDTKRDVDS | 
    3200:
    KSPGMPLFEA | EEGVLSRTQI | FPTTIKVIDP | EFLEEPPALA | FLYKDLYEEA | 
    3250:
    VGEKKKEEET | ASEGDSVNSE | ASFPSRNSDT | DDGTGIYFEK | YILKDDILHD | 
    3300:
    TSLTQKDQGQ | GLEEKRVGKD | DSYQPIAAEG | EIWGKFGTIC | REKSLEEQKG | 
    3350:
    VYGEGESVDH | VETVGNVAMQ | KKAPITEDVR | VATQKISYAV | PFEDTHHVLE | 
    3400:
    RADEAGSHGN | EVGNASPEVN | LNVPVQVSFP | EEEFASGATH | VQETSLEEPK | 
    3450:
    ILVPPEPSEE | RLRNSPVQDE | YEFTESLHNE | VVPQDILSEE | LSSESTPEDV | 
    3500:
    LSQGKESFEH | ISENEFASEA | EQSTPAEQKE | LGSERKEEDQ | LSSEVVTEKA | 
    3550:
    QKELKKSQID | TYCYTCKCPI | SATDKVFGTH | KDHEVSTLDT | AISAVKVQLA | 
    3600:
    EFLENLQEKS | LRIEAFVSEI | ESFFNTIEEN | CSKNEKRLEE | QNEEMMKKVL | 
    3650:
    AQYDEKAQSF | EEVKKKKMEF | LHEQMVHFLQ | SMDTAKDTLE | TIVREAEELD | 
    3700:
    EAVFLTSFEE | INERLLSAME | STASLEKMPA | AFSLFEHYDD | SSARSDQMLK | 
    3750:
    QVAVPQPPRL | EPQEPNSATS | TTIAVYWSMN | KEDVIDSFQV | YCMEEPQDDQ | 
    3800:
    EVNELVEEYR | LTVKESYCIF | EDLEPDRCYQ | VWVMAVNFTG | CSLPSERAIF | 
    3850:
    RTAPSTPVIR | AEDCTVCWNT | ATIRWRPTTP | EATETYTLEY | CRQHSPEGEG | 
    3900:
    LRSFSGIKGL | QLKVNLQPND | NYFFYVRAIN | AFGTSEQSEA | ALISTRGTRF | 
    3950:
    LLLRETAHPA | LHISSSGTVI | SFGERRRLTE | IPSVLGEELP | SCGQHYWETT | 
    4000:
    VTDCPAYRLG | ICSSSAVQAG | ALGQGETSWY | MHCSEPQRYT | FFYSGIVSDV | 
    4050:
    HVTERPARVG | ILLDYNNQRL | IFINAESEQL | LFIIRHRFNE | GVHPAFALEK | 
    4069:
    PGKCTLHLGI | EPPDSVRHK
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    MIM:
    UniGene:
    SMR:
    String:
    Pfam:
    Uniprot:
     
    FOR
    ELISA Kit for Human Cardiomyopathy-associated protein 5
    ELISA Kit for Human Cardiomyopathy-associated protein 5
    CLIA Kit for Human Cardiomyopathy-associated protein 5
    CLIA Kit for Human Cardiomyopathy-associated protein 5
    Polyclonal Antibody for Human Cardiomyopathy-associated protein 5
    Polyclonal Antibody for Human Cardiomyopathy-associated protein 5
    Monoclonal Antibody for Human Cardiomyopathy-associated protein 5
    Monoclonal Antibody for Human Cardiomyopathy-associated protein 5
    Protein for Human Cardiomyopathy-associated protein 5
    Protein for Human Cardiomyopathy-associated protein 5

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 2.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-1682 AND 2600-4069;VARIANTS GLY-190; VAL-1295; GLU-3583 AND LEU-4063
      tissue: Skeletal muscle.
    2. 3.
      "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
      The MGC Project Team
      Genome Res.14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-283; 1067-1340; 1604-2691 AND 2754-4069;VARIANTS GLY-1920; LEU-2262; GLN-3358; GLU-3583 AND GLN-3927
      tissue: Liver.
      tissue: Skeletal muscle.
    3. 4.
      "Complete sequencing and characterization of 21,243 full-length human cDNAs."
      Ota T. , Suzuki Y. , Nishikawa T. , Otsuki T. , Sugiyama T. , Irie R. , Wakamatsu A. , Hayashi K. , Sato H. , Nagai K. , Kimura K. , Makita H. , Sekine M. , Obayashi M. , Nishi T. , Shibahara T. , Tanaka T. , Ishii S. , more...
      Nat. Genet.36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1067-1340
      tissue: Skeletal muscle.
    4. 5.
      "Identification of altered gene expression in skeletal muscles from Duchenne muscular dystrophy patients."
      Tkatchenko A.V. , Pietu G. , Cros N. , Gannoun-Zaki L. , Auffray C. , Leger J.J. , Dechesne C.A.
      Neuromuscul. Disord.11:269-277(2001) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1736-2539;INDUCTION;TISSUE SPECIFICITY
    5. 6.
      Ding P. , Han W. , Wang L. , Wang Y. , Qiu X. , Xu M. , Ma D.
      Submitted (2002-07) to the EMBL/GenBank/DDBJ databases
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 3113-4069;VARIANT GLN-3927
      tissue: Mammary gland.
    6. 7.
      "Myospryn is a novel binding partner for dysbindin in muscle."
      Benson M.A. , Tinsley C.L. , Blake D.J.
      J. Biol. Chem.279:10450-10458(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INDUCTION
    7. 8.
      "Proper perinuclear localization of the TRIM-like protein myospryn requires its binding partner desmin."
      Kouloumenta A. , Mavroidis M. , Capetanaki Y.
      J. Biol. Chem.282:35211-35221(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH DES
    8. 9.
      "Interactions with M-band titin and calpain 3 link myospryn (CMYA5) to tibial and limb-girdle muscular dystrophies."
      Sarparanta J. , Blandin G. , Charton K. , Vihola A. , Marchand S. , Milic A. , Hackman P. , Ehler E. , Richard I. , Udd B.
      J. Biol. Chem.285:30304-30315(2010) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH CAPN3 AND TTN;SUBCELLULAR LOCATION
    Product Feedback Wall
    Hot Genes
    Atf2 ASPRO ACE ALCAM C19orf80 Trap1a Gdf5
    Top Searches
    Ubiquitin-protein ligase metalloproteinase Ubiquitin ELISA Alpha Tumor necrosis Asprosin TRAP1A
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter